Evan Tindell on X
Now that Cursor is owned by $SPCX, are corporations really going to use Grok Bot or Cursor over ChatGPT Work and Codex, regardless of how good they are? Grok / X / Elon's brand in corporate America is pretty toxic...
Search
Every article we have published, filed by the company it is actually about.
1604 articles about companies over $300M
Now that Cursor is owned by $SPCX, are corporations really going to use Grok Bot or Cursor over ChatGPT Work and Codex, regardless of how good they are? Grok / X / Elon's brand in corporate America is pretty toxic...
Overview of new Permian gas takeaway options $ET https://t.co/d6v7olZYwB
Some may not have noticed that this fellow now on the $EGBN was a 3rd party rep on the $BRBS board. Activist investor prepares for round two with Maryland bank https://t.co/j264ThuQ0C
$ACMR evolving its institutional shareholder base as its earnings power & liquidity increase: US-listed bet on China Semicap. Capital Group now top 4. Ward Ferry, 12 West, Citadel… https://t.co/7mMHvefEYe https://t.co/cY0fynu04r
The $ENVX chart looks like a battery losing its charging capacity over time… https://t.co/kOK3rpZR17
Nubank’s 140 million customers, 30%-plus ROE and 20% efficiency ratio fuel a debate over whether it is an early Capital One or a mature…
Hyperscalers need so much capital they're exporting their financing needs to...Australia $GOOG just mandated its first AUD deal. Issuance (called Kanagroo bonds) is up 40% y/y to ~A$60B (a new record) https://t.co/ZIypM3QiFx
DoorDash’s integrated autonomous-delivery strategy contrasts with Uber’s 2026 divestment of Serve Robotics, its former delivery-robot…
@ryanTesling @mact3333 @Kalshi_Finance Unless I’m not in a short-dated highly leveraged trade, I’m not paying attention to the day-to-day. I want to see $AMZN go down so I can re-lever at lower prices.
Anyone follow $LFTO closely? What price does this get interesting? https://t.co/wBRnTTafXG
Rubrik, RBRK, has risen more than 100% since a February pitch at $48; the investor updates plans for shares bought at a $53 average.
$OUST $LUNR - depending on pace of lunar expansion $CLPT $NURS.v
E.W. Scripps, Team Internet, Monro, doValue and Inter & Co feature as special-situation trades involving mergers, asset sales, leverage and…
@HugoManenti Hah! Thinking I've got any chips left! But also, imagine selling $AMZN after it went down 95% and then ripped 20% higher in '01! Nah man, tHeSe aRe sEcuLAR coMpoUndERS searching for a narrative! #neversell
Entravision’s Smadex ad-tech unit grew Q2 revenue 230% year over year, underpinning a re-rating thesis despite its legacy Spanish-language…
WHEN $FIS $GPN $FISV NO LONGER LEGACY, OVERLEVERED SHITCOS BUT 'POTENTIAL AI BENEFICIARIES' - TODAY! https://t.co/S5ilTTuxXS https://t.co/4DA9DwRteE
Cerebras Systems’ WSE-3 wafer-scale chip targets low-latency AI inference with faster decode than GPU racks, while higher per-token costs…
Whirlpool's credit curve is interesting because the belly of the curve is much wider than the long end. Typically, the further out a maturity is, the higher the credit spread required to compensate you for the additional risk. Here, the dollar price of the long bonds is so low, they carry less downside per dollar to the same recovery, plus all the torque to any good outcome (asset sales, M&A, turnaround, etc). Investors are paying a premium for that $WHR
@TheBigLong2019 Humanoid robots is AI adjacent, but I agree with you on $OUST
Hyperscalers’ off-balance-sheet lease and purchase obligations rose from roughly $1 trillion to $1.5 trillion, turning the AI buildout into…
@keisan_15 Yes that is why I liked $MEDP
I privately told a few fund managers I respect these investing themes/theses privately: "AI is going to drive far more medical/biotech research in pursuit of age reversal technologies than we had before. In fact, at least a couple of these are reasonably likely to be the most valuable companies on the planet in 10-20 years." and related, "Many of the old medical research companies are dinosaurs, since their tech will not keep up with the new age of AI driven medical research." I told them this at the start of 2025, and for example mentioned they avoid shorting $ARKG type stocks. I could tell they thought I was completely retarded, out of my mind, etc. A couple thoughts: 1. I bet those people don't think the idea is stupid at all today. and 2. Having a thesis that seems insane but is often wrong is *awesome*. It's a heads you win, tails you lose nothing situation. Besides $MEDP long, I didn't really know how to play the idea other than avoiding a bunch of shorts. These are theses I still very much believe today, and still today I don't see people talking about them.
@olliejmorgan $MEDP was like this.
@MoodyWriter13 I think $NBIS is as viable of a business as $OKLO is -- that is to say, a clear stock promote as opposed to a for-profit business. But little reason to post about it. The bulls have their view and reality will come for them in due time. I'm not going to change their mind.